Thyroid hormone resistance

Annals of Clinical Biochemistry

Volumn 43, Issue 6, 2006, Pages 431-440

  Olateju, Tolulope O ^a   Vanderpump, Mark P J ^b  

^a STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPHETAMINE; HEPARIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN; THYROXINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; COUNSELING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG ABUSE; GENE DELETION; GENE MUTATION; GOITER; HUMAN; HYPERTHYROXINEMIA; HYPOPHYSIS; HYPOPHYSIS ADENOMA; INCIDENCE; MENTAL DISEASE; METABOLIC DISORDER; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THERAPEUTIC ERROR; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; THYROXINE BLOOD LEVEL;

HUMANS; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; THYROID HORMONE RESISTANCE SYNDROME; THYROID HORMONES;

EID: 33751348275     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306778904678     Document Type: Review

References (65)

1. Verhoeven GFM, Wilson JD. The syndromes of primary hormone resistance. Metabolism 1979; 28: 253-89
2. Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism - an example of 'Seabright-Bantam Syndrome'. J Clin Endocrinol Metab 1942; 30: 922-32
3. Wilson JD, Foster DW, Kronenberg H, Larson PR. Principles of endocrinology. In: Wilson JD, Foster DW, Kronenberg H, Larson PR, eds. Williams Textbook of Endocrinology, 9th edn. Philadelphia, PA: WB Saunders Company, 1998; 1-10
4. Refetoff S, De Wind LT, DeGroot LJ. Familial syndrome combining deaf - mutism, stippled epiphyses, goitre, and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967; 27: 279-94
5. Refetoff S. Resistance to thyroid hormone. In: Braverman LE, Utiger RE, eds. Werner and Ingbars's The Thyroid: A fundamental and clinical Text, 9th edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2005; 1109-29
6. Chatterjee VK, Gurnell M. Thyroid hormone resistance syndrome. In: Wass JAH, Shalet SM, eds. Oxford Textbook of Endocrinology. London: Oxford University Press, 2002; 339-49
7. Beck-Peccoz P, Roncoroni R, Mariotti S, et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): Evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990; 71: 19-25
8. Kaplan MM, Swartz SL, Larsen PR. Partial peripheral resistance to thyroid hormone. Am J Med 1981; 70: 1115-21
9. La Franchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA. Follow-up of newborns with elevated screening T4 concentrations. J Pediatr 2003; 143: 296-301
10. Takeda K, Sakurai A, DeGroot LJ, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene. J Clin Endocrinol Metab 1992; 73: 49-55
11. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20: 321-44
12. Jameson JL. Thyroid hormone resistance: pathophysiology at the molecular level. J Clin Endocrinol Metab 1992; 74: 708-11
13. Yen PM. Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 2003; 14: 327-33
14. Sap J, Munoz A, Damm K, et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635-40
15. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DL, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986; 324: 641-6
16. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81: 1097-142
17. Zhang J, Lazar MA. The mechanism of action of thyroid hormone. Ann Rev Physiol 2000; 62: 438-66
18. Mitsuhashi T, Tennyson GE, Nikoderm VM. Alternative splicing generates messages encoding rat c-erb-A proteins that do not bind thyroid hormone. Proc Natl Acad Sci 1998; 85: 5804-5
19. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor α. Proc Natl Acad Sci 2001; 98: 349-54
20. Weiss RE, Weinberg M, Refetoff S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene: analysis of 15 families. J Clin Invest 1993; 91: 2408-15
21. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci 2001; 98: 15095-100
22. Tinnikov A, Nordstrom K, Thoren P, Kindblom JM, Malin S, Rozell B. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J 2002; 21: 5079-87
23. Liu YY, Schultz JJ, Brent GA. A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem 2003; 278: 38913-20
24. Ono S, Schwartz ID, Mueller OT, Root AW, Usala SJ, Bercu BB. Homozygosity for a 'dominant negative' thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab 1991; 73: 990-4
25. Usala SJ, Menke JB, Watson TL, Wondisford FE, Weintraub BD, Bérard JB. A homozygous deletion in the c-erb-Aβ thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol 1991; 5: 327-35
26. Bassett DJH, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 2003; 14: 356-64
27. Johansson C, Göthe S, Forrest D, Vennström B, Thorén P. Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor β or both a1 and β. Am J Physiol 1999; 276: H2006-12
28. Gloss B, Trost SU, Bluhm WF, Swanson EA, Clark R, Winkfein R. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor alpha or ss. Endocrinology 2001; 142: 544-50
29. Kahaly GJ, Matthews CH, Mohr-Kahaly S, Richards CA, Chatterjee VK. Cardiac involvement in thyroid hormone resistance. J Clin Endocrinol Metab 2002; 87: 204-12
30. Mixson AJ, Hauser P, Tennyson G, Renault JC, Bodenner DL, Weintraub BD. Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. J Clin Invest 1993; 91: 2296-300
31. Hayashi Y, Janssen OE, Weiss RE, Murata Y, Seo H, Refetoff S. The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products. J Clin Endocrinol Metab 1993; 76: 64-69
32. Sadow P, Reutrakul S, Weiss RE, Refetoff S. Resistance to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes. Curr Opin Endocrinol Diab 2000; 7: 253-9
33. Hao E, Menke JB, Smith AM, Jones C, Geffer ME, Hershman JM. Divergent dimerization properties of mutant β1 thyroid hormone receptors are associated with different dominant negative activities. Mol Endocrinol 1994; 8: 841-51
34. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC. Variable transcriptional activity and ligand binding of mutant β1 3,5,3-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 1992; 6: 248-58
35. Nagaya T, Eberhardt NL, Jameson JL. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 1993; 77: 982-90
36. Beck-Peccoz P, Chatterjee VKK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225-32
37. Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993; 328: 997-1001
38. Weiss RE, Stein MA, Trommer B, Refetoff S. Attention-deficit hyperactivity disorder and thyroid function. J Pediatr 1993; 123: 539-45
39. Elia J, Gulotta C, Rose SR, Marin G, Rapoport J. Thyroid function and attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1994; 33: 169-72
40. Weiss RE, Stein MA, Duck SC, Chyna B, Phillips W, O'Brien T. Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor β gene. J Clin Endocrinol Metab 1994; 78: 1525-8
41. Ando S, Sarlis NJ, Krishan J, Feng X, Refetoff S, Zhang MQ. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 2001; 15: 1529-38
42. Sarne DH, Sobieszczyk S, Ain KB, Refetoff S. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: Responses to thyrotropin-releasing hormone stimulation and triiodothyronine suppression. J Clin Endocrinol Metab 1990; 70: 1305-11
43. Kasai Y, Aritaki S, Utsunomiya M, Matsuno T. Twin sisters with Refetoff's Syndrome. J Jpn Pediatr Assoc 1983; 87: 1203-12
44. Hughes IA, Ichikawa K, DeGroot LJ, John R, Jones MK, Hall R. Non-adenomatous inappropriate TSH hypersecretion and euthyroidism requires no treatment. Clin Endocrinol 1987; 27: 475-83
45. Persani L, Borgato S, Romoli R, Asteria C, Pizzocardo A, Beck-Peccoz P. Changes in the degree of sialylation of carbohydrate chain modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 1998; 83: 2486-92
46. Persani L, Asteria C, Tonacchera M, Vitti P, Chatterjee VKK, Beck-Peccoz P. Evidence for secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J Clin Endocrinol Metab 1994; 78: 1034-9
47. Lamberg BA, Rosengård S, Liwendahl K, Säarinen P, Evered DC. Familial partial peripheral resistance to thyroid hormones. Acta Endocrinol 1978; 87: 303-12
48. Chatterjee VKK, Beck-Peccoz P. The variable clinical phenotype in thyroid hormone resistance syndrome. Ballieres Clin Endocrinol Metab 1994; 8: 267-83
49. Beck-Peccoz P, Persani L, Faglia G. Glycoprotein hormone a-subunit in pituitary adenomas. Trends Endocrinol Metab 1992; 3: 41-5
50. Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D. Prenatal diagnosis of thyroid hormone receptors. J Clin Endocrinol Metab 1999; 84: 405-10
51. Anselmo J, Refetoff S. Regression of a large goitre in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine. Thyroid 2004; 14: 71-4
52. Hamon P, Bevier Lapeer M, Robert M, Pentad D, Pugeat M. Hyperthyroidism due to selective pituitary resistance to thyroid hormone in a 15 month old: efficacy of D-thyroxine treatment. J Clin Endocrinol Metab 1988; 67: 1089-93
53. Dorey F, Stauch G, Gayno JP. Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D-thyroxine: a study in 3 patients. Clin Endocrinol 1990; 32: 221-228
54. Krawczynska H, Wojcik-Musialek K, Ilig R. 10 years of successful treatment with dextrothyroxine in a girl with TSH-induced hyperthyroidism. Horm Res 1991; 35: 213-6
55. Takeda T, Suzuki S, Rue-Tsuan L, DeGroot LJ. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 1995; 80: 2033-41
56. Goslings B, Schwartz HL, Dillmann W, Surks MI, Oppenheimer JH. Comparison of the metabolism and distribution of L-T3 and Triac in the rat: a possible explanation of differential hormone potency. Endocrinology 1976; 98: 666-75
57. Beck-Peccoz P, Piscitelli G, Cattaneo MG, Faglia G. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3′5′'3-triiodothyroacetic acid (TRIAC). J Endocrinol Invest 1983; 6: 217-23
58. Orgiazzi J, Ducottet X, Barbier Y, Jordan D, Pugeat M, Morin MH. Inappropriate TSH hypersecretion: opposite effect of T4 and T3 on the thyrotrophs? Ann Endocrinol (Paris) 1985; 45: 86A
59. Kunitake JM, Hartman N, Henson LC, et al. 3,5,3′-Triiodothyroacetic acid therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1989; 75: 1071-5
60. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone - primum non noncere. J Clin Endocrinol Metab 1999; 84: 401-4
61. Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM. Bromocriptine and TRIAC therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1992; 75: 1071-5
62. Salmela PI, Wide L, Juustila H, Ruokonen A. Effects of thyroid hormones (T4, T3), bromocriptine and TRIAC on inappropriate TSH hypersecretion. Clin Endocrinol (Oxford) 1988; 28: 497-501
63. Sriwatanakul K, Mc Cormick K, Woolf P. Thyrotropin (TSH) induced hyperthyroidism: response of TSH to dopamine and its agonist. J Clin Endocrinol Metab 1977; 58: 255-61
64. Samaan NA, Osborne BM, Mackay B, Leavens ME, Duello TM, Halmi NS. Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism. J Clin Endocrinol Metab 1977; 45: 903-11
65. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knock-out and knock-in mutant mice. Trends Endocrinol Metab 2003; 14: 85-90